Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo

Osteoprotegerin (OPG) is a secreted member of the tumor necrosis factor (TNF) receptor superfamily that binds to the ligand for receptor activator of nuclear factor κB (RANKL) and inhibits bone resorption. OPG can also bind and inhibit the activity of the TNF‐related apoptosis‐inducing ligand (Apo2L...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Bone Miner Res
Main Authors: Zinonos, Irene, Labrinidis, Agatha, Lee, Michelle, Liapis, Vasilios, Hay, Shelley, Ponomarev, Vladimir, Diamond, Peter, Findlay, David M, Zannettino, Andrew CW, Evdokiou, Andreas
Format: Artigo
Sprog:Inglês
Udgivet: Wiley Subscription Services, Inc., A Wiley Company 2011
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568243/
https://ncbi.nlm.nih.gov/pubmed/20818644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.244
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker